Anzeige
Mehr »
Freitag, 01.05.2026 - Börsentäglich über 12.000 News
Öl bricht über $108 und Wedgemount dreht die Produktion genau jetzt wieder an
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Insider Monkey

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiHere is Why SLB (SLB) is One of the Best Performing S&P 500 Stocks
MiNVR, Inc. (NVR)'s First-quarter Profit Drops
MiHome Depot (HD) Solves a Critical Customer Pain Point to Win over Shoppers
MiEvercore ISI Maintains an "In Line" Rating on Lowe's Companies, Inc. (LOW)
MiEvercore ISI l Maintains an Underperform Rating on Lennar Corporation (LEN)
MiD.R. Horton (DHI) Beats Annual Revenue Forecast Estimates
MiBofA Retains a Neutral Rating on Builders FirstSource, Inc. (BLDR)
MiEvercore Maintains an "In Line" Rating on KB Home (KBH)
MiToll Brothers (TOL) to Acquire Assets of Buffington Homes of Arkansas
MiProcter & Gamble (PG): The Best Consumer Staples Stock to Invest In
MiStifel Maintains Buy Rating on Monster Beverage (MNST)
MiTD Cowen Maintains Buy Rating on e.l.f. Beauty (ELF)
MiMorgan Stanley Maintains Equal Weight Rating on J. M. Smucker (SJM)
MiBJ's Wholesale Club (BJ) Expands into Texas
MiJPMorgan Raises its Price Target on JBS N.V. (JBS) to $20.50
MiJPMorgan Maintains Neutral Rating on Church & Dwight (CHD)
MiTD Cowen Maintains Hold Rating on Estée Lauder (EL)
MiBofA Maintains Buy Rating on Sysco (SYY)
MiKKR & Co. (KKR) Falls on Earnings Miss Despite Strong Fundraising Momentum and Long-Term Growth Plans
MiCorcept Therapeutics (CORT) Inspires Confidence with ROSELLA Phase 3 Survival Data
MiBeam Therapeutics (BEAM) Reveals Encouraging Results From Risto-Cel Phase 1/2 BEACON Study
MiOptimism Surrounds Praxis Precision Medicines (PRAX) Amid Potential FDA Approval for Ulixacaltamide
MiWhat Makes Denali Therapeutics (DNLI) One of the Best Biotech Stocks to Invest in
MiUltragenyx Pharmaceutical (RARE) Garnering Bullish Sentiment With Forthcoming GTX-102 Phase 3 Angelman Trial
MiH.C. Wainwright Reaffirms Buy Rating for Legend Biotech (LEGN)